US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Korro Bio, Inc.

35.82

+2.898.78%

Volume:152.69K

Turnover:5.22M

Market Cap:336.34M

PE:-3.67

High:36.00

Open:33.00

Low:32.75

Close:32.93

52wk High:98.00

52wk Low:10.29

Shares:9.39M

Float Shares:5.74M

Volume Ratio:0.68

T/O Rate:2.66%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.7577

EPS(LYR):-9.3695

ROE:-58.34%

ROA:-28.65%

PB:2.92

PE(LYR):-3.82

Loading ...

Overview Company News Filings

BRIEF-Korro Bio Inc - Announces 20% Workforce Reduction - SEC Filing

Korro Bio Q1 EPS $(2.49) Beats $(2.61) Estimate, Sales $2.55M Beat $180.00K Estimate

Press Release: Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

Cantor Fitzgerald Initiates Korro Bio at Overweight $74 Price Target

MT Newswires Live

Korro Bio Initiated at Buy by Chardan Capital

U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia

Press Release: Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer

Korro Bio CFO Resumes Role After Temporary Medical Leave

MT Newswires Live

BRIEF-Korro Bio Inc Vineet Agarwal Ends Temporary Medical Leave As CFO

Korro Bio Price Target Maintained With a $115.00/Share by HC Wainwright & Co.

RBC Cuts Price Target on Korro Bio to $95 From $105, Keeps Outperform, Speculative Risk

MT Newswires Live

U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY

Korro Bio 2020 EPS $(9.37)

Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KRRO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":35.815,"timestamp":1757435742680,"preClose":32.925,"halted":0,"volume":152691,"delay":0,"floatShares":5744014,"shares":9390903,"eps":-9.757734,"marketStatus":"Trading","change":2.89,"latestTime":"09-09 12:35:43 EDT","open":33,"high":36,"low":32.75,"amount":5224733.761863,"amplitude":0.098709,"askPrice":35.99,"askSize":300,"bidPrice":35.49,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-9.757734,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1757448000000},"marketStatusCode":2,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":32.925,"preHourTrading":{"tag":"盘前","latestPrice":32,"preClose":32.925,"latestTime":"09:19 EDT","volume":142,"amount":4544,"timestamp":1757423997243},"postHourTrading":{"tag":"盘后","latestPrice":32.27,"preClose":32.925,"latestTime":"19:06 EDT","volume":275,"amount":8940.185,"timestamp":1757372787902},"volumeRatio":0.676378},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","floatShares":5744014,"roa":"-28.65%","roe":"-58.34%","lyrEps":-9.369477,"volumeRatio":0.676378,"shares":9390903,"dividePrice":0,"high":36,"amplitude":0.098709,"preClose":32.925,"low":32.75,"week52Low":10.29,"pbRate":"2.92","psRate":"53.55","week52High":98,"institutionHeld":0,"latestPrice":35.815,"committee":-0.967213,"eps":-9.757734,"divideRate":0,"volume":152691,"delay":0,"ttmEps":-9.757734,"open":33,"prevYearClose":38.07,"prevWeekClose":33.18,"prevMonthClose":23.08,"prevQuarterClose":12.49,"fiveDayClose":22.205,"twentyDayClose":15.05,"sixtyDayClose":13.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"KRRO","fiscalQuarterEnding":"2025/06","expectedEps":-2.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-2.74},{"market":"US","date":"2025-05-07","symbol":"KRRO","fiscalQuarterEnding":"2025/03","expectedEps":-2.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-2.49},{"market":"US","date":"2025-03-18","symbol":"KRRO","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-2.26},{"market":"US","date":"2024-11-12","symbol":"KRRO","fiscalQuarterEnding":"2024/09","expectedEps":-2.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-2.26},{"market":"US","date":"2024-08-13","symbol":"KRRO","fiscalQuarterEnding":"2024/06","expectedEps":-2.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1746072000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRRO","date":"2025-09-08","current":-3.410762,"percent":0.674312,"low":-8.894386,"twenty":-5.834772,"median":-4.39564,"eighty":-1.959761,"high":-1.160235,"avg":-4.255166,"sd":1.954822,"marketCap":311590161},"quantilePoints":[{"date":"2023-11-10","current":-4.581336,"twenty":-4.600294,"median":-4.593185,"eighty":-4.586076,"marketCap":328848276},{"date":"2023-11-17","current":-4.545683,"twenty":-4.815324,"median":-4.662668,"eighty":-4.586076,"marketCap":326289146},{"date":"2023-11-24","current":-4.263806,"twenty":-4.730727,"median":-4.581336,"eighty":-4.305029,"marketCap":306056020},{"date":"2023-12-01","current":-4.669353,"twenty":-4.669353,"median":-4.511145,"eighty":-4.263806,"marketCap":335166130},{"date":"2023-12-08","current":-5.29327,"twenty":-5.459276,"median":-4.605034,"eighty":-4.305029,"marketCap":379950915},{"date":"2023-12-15","current":-5.927214,"twenty":-5.596315,"median":-4.70004,"eighty":-4.344024,"marketCap":425455455},{"date":"2023-12-22","current":-5.775692,"twenty":-5.775692,"median":-5.29327,"eighty":-4.447639,"marketCap":414579150},{"date":"2023-12-29","current":-5.477103,"twenty":-5.763659,"median":-5.468189,"eighty":-4.46502,"marketCap":393146432},{"date":"2024-01-05","current":-5.57069,"twenty":-5.744941,"median":-5.477103,"eighty":-4.490422,"marketCap":399864150},{"date":"2024-01-12","current":-4.878811,"twenty":-5.700822,"median":-5.48323,"eighty":-4.552814,"marketCap":350201022},{"date":"2024-01-19","current":-4.570194,"twenty":-5.695474,"median":-5.467075,"eighty":-4.570194,"marketCap":328048548},{"date":"2024-01-26","current":-5.793518,"twenty":-5.702159,"median":-5.459276,"eighty":-4.579107,"marketCap":415858716},{"date":"2024-02-02","current":-5.903818,"twenty":-5.702159,"median":-5.475988,"eighty":-4.581336,"marketCap":423776026},{"date":"2024-02-09","current":-6.542219,"twenty":-5.793518,"median":-5.496043,"eighty":-4.605034,"marketCap":469600457},{"date":"2024-02-16","current":-6.005204,"twenty":-5.995177,"median":-5.561777,"eighty":-4.662668,"marketCap":431053553},{"date":"2024-02-23","current":-5.637539,"twenty":-6.009661,"median":-5.57459,"eighty":-4.668016,"marketCap":404662519},{"date":"2024-03-01","current":-5.381287,"twenty":-5.997182,"median":-5.57069,"eighty":-4.718452,"marketCap":386268768},{"date":"2024-03-08","current":-5.46819,"twenty":-5.954177,"median":-5.56679,"eighty":-4.734215,"marketCap":392506649},{"date":"2024-03-15","current":-6.597926,"twenty":-6.029715,"median":-5.57069,"eighty":-4.778761,"marketCap":473599099},{"date":"2024-03-22","current":-7.241897,"twenty":-6.148928,"median":-5.582946,"eighty":-4.827114,"marketCap":519823395},{"date":"2024-03-28","current":-8.749112,"twenty":-6.225581,"median":-5.594644,"eighty":-4.85118,"marketCap":710182879},{"date":"2024-04-05","current":-7.056213,"twenty":-6.445289,"median":-5.625283,"eighty":-4.87168,"marketCap":572766944},{"date":"2024-04-12","current":-7.760846,"twenty":-6.653602,"median":-5.643524,"eighty":-4.982426,"marketCap":629963419},{"date":"2024-04-19","current":-6.599635,"twenty":-6.850878,"median":-5.695474,"eighty":-5.142416,"marketCap":535705553},{"date":"2024-04-26","current":-6.686174,"twenty":-6.869775,"median":-5.765664,"eighty":-5.203025,"marketCap":542730135},{"date":"2024-05-03","current":-6.650761,"twenty":-6.964451,"median":-5.793518,"eighty":-5.219737,"marketCap":539855604},{"date":"2024-05-10","current":-6.269217,"twenty":-6.920952,"median":-5.915516,"eighty":-5.240905,"marketCap":508884843},{"date":"2024-05-17","current":-5.859151,"twenty":-6.869775,"median":-5.859151,"eighty":-5.274998,"marketCap":475317730},{"date":"2024-05-24","current":-5.495668,"twenty":-6.850878,"median":-5.84806,"eighty":-5.34608,"marketCap":445830598},{"date":"2024-05-31","current":-5.743893,"twenty":-6.8128,"median":-5.816278,"eighty":-5.412483,"marketCap":465967596},{"date":"2024-06-07","current":-5.114065,"twenty":-6.734223,"median":-5.793518,"eighty":-5.389162,"marketCap":414873438},{"date":"2024-06-14","current":-4.858019,"twenty":-6.694902,"median":-5.775692,"eighty":-5.295379,"marketCap":394101947},{"date":"2024-06-21","current":-4.102454,"twenty":-6.686174,"median":-5.755637,"eighty":-5.203025,"marketCap":332807503},{"date":"2024-06-28","current":-3.825833,"twenty":-6.685159,"median":-5.743893,"eighty":-5.149649,"marketCap":310366874},{"date":"2024-07-05","current":-4.380219,"twenty":-6.677519,"median":-5.73799,"eighty":-4.872237,"marketCap":355340861},{"date":"2024-07-12","current":-5.240945,"twenty":-6.652589,"median":-5.708166,"eighty":-4.858612,"marketCap":425166453},{"date":"2024-07-15","current":-5.618156,"twenty":-6.652132,"median":-5.702159,"eighty":-4.859205,"marketCap":455767311},{"date":"2024-08-02","current":-4.971182,"twenty":-6.651675,"median":-5.698816,"eighty":-4.859798,"marketCap":403282204},{"date":"2024-08-09","current":-4.113885,"twenty":-6.640451,"median":-5.660935,"eighty":-4.773204,"marketCap":333734802},{"date":"2024-08-16","current":-4.916432,"twenty":-6.613212,"median":-5.643524,"eighty":-4.733343,"marketCap":419376556},{"date":"2024-08-23","current":-4.817231,"twenty":-6.59861,"median":-5.625283,"eighty":-4.733343,"marketCap":410914634},{"date":"2024-08-30","current":-5.446229,"twenty":-6.597297,"median":-5.604672,"eighty":-4.737935,"marketCap":464568797},{"date":"2024-09-06","current":-4.658074,"twenty":-6.575014,"median":-5.590187,"eighty":-4.732471,"marketCap":397338364},{"date":"2024-09-13","current":-4.408437,"twenty":-6.520293,"median":-5.578489,"eighty":-4.665342,"marketCap":376044078},{"date":"2024-09-20","current":-4.196954,"twenty":-6.477243,"median":-5.57069,"eighty":-4.6075,"marketCap":358004377},{"date":"2024-09-27","current":-3.78816,"twenty":-6.457997,"median":-5.564005,"eighty":-4.555487,"marketCap":323133821},{"date":"2024-10-04","current":-3.412069,"twenty":-6.444854,"median":-5.520554,"eighty":-4.463176,"marketCap":291052909},{"date":"2024-10-11","current":-3.984381,"twenty":-6.396267,"median":-5.495668,"eighty":-4.391506,"marketCap":339871688},{"date":"2024-10-18","current":-8.722034,"twenty":-6.444854,"median":-5.494185,"eighty":-4.372675,"marketCap":743998188},{"date":"2024-10-25","current":-7.426973,"twenty":-6.575014,"median":-5.518326,"eighty":-4.380219,"marketCap":633528265},{"date":"2024-10-31","current":-6.633368,"twenty":-6.626621,"median":-5.552864,"eighty":-4.385863,"marketCap":565832892},{"date":"2024-11-08","current":-7.532715,"twenty":-6.647324,"median":-5.570133,"eighty":-4.416277,"marketCap":642548116},{"date":"2024-11-15","current":-5.302508,"twenty":-6.677519,"median":-5.57069,"eighty":-4.447647,"marketCap":465602621},{"date":"2024-11-22","current":-5.400663,"twenty":-6.652589,"median":-5.56679,"eighty":-4.448989,"marketCap":474221422},{"date":"2024-11-29","current":-5.554297,"twenty":-6.650761,"median":-5.56679,"eighty":-4.454222,"marketCap":487711719},{"date":"2024-12-06","current":-4.173725,"twenty":-6.633578,"median":-5.554297,"eighty":-4.447681,"marketCap":366486409},{"date":"2024-12-13","current":-4.690106,"twenty":-6.633368,"median":-5.55038,"eighty":-4.454222,"marketCap":411828797},{"date":"2024-12-20","current":-4.600486,"twenty":-6.599635,"median":-5.518326,"eighty":-4.476607,"marketCap":403959457},{"date":"2024-12-27","current":-4.39564,"twenty":-6.598268,"median":-5.495668,"eighty":-4.47213,"marketCap":385972394},{"date":"2025-01-03","current":-4.376436,"twenty":-6.597297,"median":-5.489358,"eighty":-4.431958,"marketCap":384286107},{"date":"2025-01-10","current":-4.013689,"twenty":-6.580078,"median":-5.474874,"eighty":-4.400759,"marketCap":352434016},{"date":"2025-01-17","current":-3.945407,"twenty":-6.549815,"median":-5.463733,"eighty":-4.371161,"marketCap":346438328},{"date":"2025-01-24","current":-4.049964,"twenty":-6.531256,"median":-5.447319,"eighty":-4.329948,"marketCap":355619225},{"date":"2025-01-31","current":-3.646675,"twenty":-6.482324,"median":-5.400974,"eighty":-4.264567,"marketCap":320207195},{"date":"2025-02-07","current":-3.864323,"twenty":-6.459999,"median":-5.376271,"eighty":-4.20066,"marketCap":339318449},{"date":"2025-02-14","current":-3.102554,"twenty":-6.448423,"median":-5.308909,"eighty":-4.176092,"marketCap":272429058},{"date":"2025-02-21","current":-3.056677,"twenty":-6.434147,"median":-5.302508,"eighty":-4.119313,"marketCap":268400706},{"date":"2025-02-28","current":-2.638451,"twenty":-6.340126,"median":-5.244267,"eighty":-4.093707,"marketCap":231677119},{"date":"2025-03-07","current":-2.367458,"twenty":-6.339446,"median":-5.203025,"eighty":-4.06287,"marketCap":207881733},{"date":"2025-03-14","current":-2.630983,"twenty":-6.269217,"median":-5.198397,"eighty":-4.049964,"marketCap":231021340},{"date":"2025-03-21","current":-2.460092,"twenty":-6.255885,"median":-5.114065,"eighty":-3.984381,"marketCap":205616953},{"date":"2025-03-28","current":-2.06468,"twenty":-6.247779,"median":-5.067789,"eighty":-3.960398,"marketCap":172568018},{"date":"2025-04-04","current":-1.656911,"twenty":-6.240921,"median":-5.016723,"eighty":-3.945407,"marketCap":138486304},{"date":"2025-04-11","current":-1.456959,"twenty":-6.236945,"median":-4.994706,"eighty":-3.88409,"marketCap":121774058},{"date":"2025-04-17","current":-1.512002,"twenty":-6.221793,"median":-4.974969,"eighty":-3.861976,"marketCap":126374620},{"date":"2025-04-25","current":-1.959087,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"marketCap":163742450},{"date":"2025-05-02","current":-2.066365,"twenty":-6.177673,"median":-4.874702,"eighty":-3.775951,"marketCap":172708852},{"date":"2025-05-09","current":-1.654409,"twenty":-6.170108,"median":-4.860984,"eighty":-3.687236,"marketCap":144613576},{"date":"2025-05-16","current":-1.555575,"twenty":-6.148652,"median":-4.836663,"eighty":-3.631696,"marketCap":135974324},{"date":"2025-05-23","current":-1.591026,"twenty":-6.130879,"median":-4.78968,"eighty":-3.512031,"marketCap":139073186},{"date":"2025-05-30","current":-1.260144,"twenty":-6.108373,"median":-4.78372,"eighty":-3.223328,"marketCap":110150471},{"date":"2025-06-06","current":-1.32675,"twenty":-6.061356,"median":-4.749297,"eighty":-3.117918,"marketCap":115972576},{"date":"2025-06-13","current":-1.50186,"twenty":-6.034499,"median":-4.735087,"eighty":-2.776295,"marketCap":131279078},{"date":"2025-06-20","current":-1.338568,"twenty":-6.030043,"median":-4.699133,"eighty":-2.705652,"marketCap":117005530},{"date":"2025-06-27","current":-1.325676,"twenty":-6.018574,"median":-4.677957,"eighty":-2.666335,"marketCap":115878671},{"date":"2025-07-03","current":-1.43418,"twenty":-6.003199,"median":-4.660916,"eighty":-2.628422,"marketCap":125363068},{"date":"2025-07-11","current":-1.459963,"twenty":-5.99384,"median":-4.62319,"eighty":-2.383248,"marketCap":127616786},{"date":"2025-07-18","current":-1.485746,"twenty":-5.986149,"median":-4.615445,"eighty":-2.328623,"marketCap":129870504},{"date":"2025-07-25","current":-1.708124,"twenty":-5.970205,"median":-4.600486,"eighty":-2.093296,"marketCap":149308822},{"date":"2025-08-01","current":-1.607141,"twenty":-5.940584,"median":-4.57486,"eighty":-1.999527,"marketCap":140481760},{"date":"2025-08-08","current":-1.703827,"twenty":-5.922535,"median":-4.545683,"eighty":-1.959761,"marketCap":148933203},{"date":"2025-08-15","current":-2.043579,"twenty":-5.895837,"median":-4.518539,"eighty":-1.949427,"marketCap":186691151},{"date":"2025-08-22","current":-2.112452,"twenty":-5.862962,"median":-4.454222,"eighty":-1.956391,"marketCap":192983056},{"date":"2025-08-29","current":-2.433175,"twenty":-5.854715,"median":-4.430175,"eighty":-1.959087,"marketCap":222282674},{"date":"2025-09-05","current":-2.887018,"twenty":-5.836969,"median":-4.402038,"eighty":-1.959087,"marketCap":263743510},{"date":"2025-09-08","current":-3.410762,"twenty":-5.834772,"median":-4.39564,"eighty":-1.959761,"marketCap":311590161}],"updateTime":1757435743251},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRRO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533938459","title":"BRIEF-Korro Bio Inc - Announces 20% Workforce Reduction - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2533938459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533938459?lang=en_us&edition=fundamental","pubTime":"2025-05-08 06:04","pubTimestamp":1746655482,"startTime":"0","endTime":"0","summary":"BRIEF-Korro Bio Inc - Announces 20% Workforce Reduction - SEC FilingKorro Bio Inc KRRO.O:KORRO BIO INC - ANNOUNCES 20% WORKFORCE REDUCTION - SEC FILINGSource text: [ID:n0000950170-25-065786]Further company coverage: KRRO.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF1WY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2533649979","title":"Korro Bio Q1 EPS $(2.49) Beats $(2.61) Estimate, Sales $2.55M Beat $180.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533649979","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533649979?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:40","pubTimestamp":1746650451,"startTime":"0","endTime":"0","summary":"Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.49) per share which beat the analyst consensus estimate of $(2.61) by 4.6 percent. This is a 2.05 percent decrease over losses of $(2.44) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45268204/korro-bio-q1-eps-2-49-beats-2-61-estimate-sales-2-55m-beat-180-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2533297961","title":"Press Release: Korro Reports First Quarter 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2533297961","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533297961?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:30","pubTimestamp":1746649800,"startTime":"0","endTime":"0","summary":"--  Interim readout from Phase 1/2a REWRITE clinical trial. reductions expected to extend cash runway into 2027. --  Second development candidate expected to be announced. --  Ended first quarter 2025 with $139.0 million in cash,Ram Aiyar, Ph.D., CEO and President of Korro, said, \"We remain on track to achieve our clinical and pipeline milestones, most notably reporting interim data from our Phase 1/2a REWRITE clinical trial of KRRO-110 in the second half of 2025. We believe that KRRO-110 represents a groundbreaking therapy with best-in-class potential for patients with AATD. At the same time, we remain focused on executing our 3-2-1 strategy through 2027 with the goal of developing novel genetic medicines to improve lives of patients with rare and highly prevalent diseases.\". generating program milestones. Korro is streamlining its operations. across the organization and reducing its workforce by approximately 20%. to advance its programs to key value inflection points, including. sec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4555","BK4139","BK4604","BK4588","TM","KRRO","RNA","03160","BK4505","BK4585"],"gpt_icon":0},{"id":"2531878910","title":"Cantor Fitzgerald Initiates Korro Bio at Overweight $74 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2531878910","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531878910?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:17","pubTimestamp":1745925479,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of buy and mean price target of $111.89, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO"],"gpt_icon":0},{"id":"2527297873","title":"Korro Bio Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2527297873","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527297873?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:20","pubTimestamp":1744802400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 16, 2025 07:20 ET (11:20 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2527525939","title":"U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2527525939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527525939?lang=en_us&edition=fundamental","pubTime":"2025-04-16 15:47","pubTimestamp":1744789663,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-3M, Citigroup, Nvidia April 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including 3M, Citigroup and N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU0JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXTA","LU0256863902.USD","ARI","LNN","IE00BN0W2T93.GBP","HON","KRRO","IEX","CPAY","LU1496350171.SGD","FBK","AGNC","FTV","CGON","EPAM","IE00B42XCP33.USD","JBHT","ATO","BOW","IBKR","KREF","FLS","DOV","FLNC","ABR","NLY","BXMT","LU0640476718.USD","GTES","HWC","CAH","MCK","GO","MMM","COR","EMR","BK4533","GGG","BE","CARR","LU2468319806.SGD","LU1721427968.SGD","AOS","LII","LU1934455863.HKD","CCNE","IE00BQXX3F31.USD","BMI","AME"],"gpt_icon":1},{"id":"2524978661","title":"Press Release: Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524978661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524978661?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:30","pubTimestamp":1743507000,"startTime":"0","endTime":"0","summary":"Strengthens leadership team with additional key appointment of GaoZhong Zhu, Ph.D. as Senior Vice President of Chemistry, Manufacturing and Controls  & Technical Operations and promotion of Oliver Dolan to Principal Accounting Officer. CAMBRIDGE, Mass., April 01, 2025  -- Korro Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today the appointment of Loc Vincent, Ph.D., as the Company's Chief Scientific Officer.\"We are excited to welcome Dr. Vincent, whose extensive drug development experience and expertise in translating groundbreaking science into therapies will be instrumental in leading our scientific team and strategy,\" said Ram Aiyar, Ph.D., CEO and President of Korro. \"He joins us at an important time as we advance multiple candidates in our pipeline, including KRRO-110, which is currently being evaluated in the Phase 1/2a REWRITE clinical stu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0267386448.USD","LU1363072403.SGD","BK4139","KRRO","IE00BHPRN162.USD","CMC","LU0971096721.USD","IE00BZ1G4Q59.USD","IE00B1BXHZ80.USD","LU0149725797.USD","LU0882574139.USD","IE00BKVL7J92.USD","BK4006","LU0170899867.USD"],"gpt_icon":0},{"id":"2522078183","title":"Korro Bio CFO Resumes Role After Temporary Medical Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2522078183","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522078183?lang=en_us&edition=fundamental","pubTime":"2025-03-27 22:28","pubTimestamp":1743085712,"startTime":"0","endTime":"0","summary":"Korro Bio  said Thursday that Chief Financial Officer Vineet Agarwal ended his temporary medical leave of absence and was reappointed by the board as principal financial officer of the company.Chief Executive Ram Aiyar will no longer be the interim principal financial officer, according to the company.The board also appointed Oliver Dolan as principal accounting officer, Korro said.Shares of the company were marginally higher in recent trading.Price: 17.83, Change: +0.06, Percent Change: +0.37","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2522306823","title":"BRIEF-Korro Bio Inc Vineet Agarwal Ends Temporary Medical Leave As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2522306823","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522306823?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:18","pubTimestamp":1743081486,"startTime":"0","endTime":"0","summary":"BRIEF-Korro Bio Inc Vineet Agarwal Ends Temporary Medical Leave As CFOMarch 27  - Korro Bio Inc KRRO.O:KORRO BIO INC - VINEET AGARWAL ENDS TEMPORARY MEDICAL LEAVE AS CFO - SEC FILINGKORRO BIO INC - REAPPOINTS VINEET AGARWAL AS PRINCIPAL FINANCIAL OFFICERFurther company coverage: KRRO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2520434164","title":"Korro Bio Price Target Maintained With a $115.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520434164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520434164?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:28","pubTimestamp":1742466480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2025 06:28 ET (10:28 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2520970073","title":"RBC Cuts Price Target on Korro Bio to $95 From $105, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2520970073","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520970073?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:24","pubTimestamp":1742379887,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of buy and mean price target of $138.83, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO"],"gpt_icon":0},{"id":"2520294796","title":"U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY","url":"https://stock-news.laohu8.com/highlight/detail?id=2520294796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520294796?lang=en_us&edition=fundamental","pubTime":"2025-03-19 15:35","pubTimestamp":1742369743,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AT&T, Brighthouse Financial, ETSY March 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AT&T, B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4N3Q20KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4554","LU1267930730.SGD","LU0672654240.SGD","LU2384288077.EUR","LU2458330169.SGD","LU1923621640.USD","RRC","T","LU0342679015.USD","KRRO","LU0557290698.USD","LU0198837287.USD","LU2095319765.USD","LU0109391861.USD","IE00B5TLWC47.USD","LU2236285917.USD","LU1712237335.SGD","BK4515","LU0861579265.USD","LU0472753341.HKD","LU0965509283.SGD","LU2125910336.SGD","PTMN","IE00BFXG1179.USD","LU0081259029.USD","LU0354030511.USD","LU2125154778.USD","BK4585","BK4550","LU2065170008.USD","PYXS","LU1633808545.USD","BK4534","BK4507","BK4220","BK4122","LU1778281490.HKD","FERG","LU2360032135.SGD","TNDM","BHF","LU1803068979.SGD","ETSY","BK4567","LU0289961442.SGD","CMG","LU0158827948.USD","BK4023"],"gpt_icon":1},{"id":"2520779623","title":"Korro Bio 2020 EPS $(9.37)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520779623","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520779623?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:06","pubTimestamp":1742296011,"startTime":"0","endTime":"0","summary":"Korro Bio 2020 EPS $(9.37)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44373123/korro-bio-2020-eps-9-37","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Korro Bio 2020 EPS $(9.37)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2520623331","title":"Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2520623331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520623331?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:00","pubTimestamp":1742295600,"startTime":"0","endTime":"0","summary":"--  Completed dosing of first two cohorts in Phase 1/2a. REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin. --  U.S. Food and Drug Administration  Granted Orphan. programs, targeting two tissue types with a single. Clinical Advisory Board and key additions to board. \"KRRO-110 has best-in-class potential based on our preclinical data, and we are excited to potentially demonstrate this in PiZZ patients in the second half of 2025 with the interim data readout of REWRITE. We also anticipate announcing our second development candidate by the end of 2025. Our strategy of taking three development candidates in two tissue types with a single RNA-editing platform in the clinic by the end of 2027 will expand the possibilities of RNA editing, underscoring our commitment to progressing both our wholly owned and partnered programs.\". to progress enrollment in Australia, and potential expansion into. multiple jurisdictions, including the United States. An interim readout. is expected in the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4585","CMC","IE00BZ1G4Q59.USD","TM","BK4006","LU0882574139.USD","LU0170899867.USD","BK4604","IE00BKVL7J92.USD","LU0149725797.USD","RNA","BK4099","LU0267386448.USD","IE00BHPRN162.USD","KRRO","BK4505","BK4139","LU1363072403.SGD","03160","IE00B1BXHZ80.USD","BK4588","LU0971096721.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":38,"code":"91000000","status":"200"}]}}